ACURA PHARMACEUTICALS INC (ACUR) Financials
ACUR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2021-12-31 | ? | ? |
2021-09-30 | 1.4 million | 1.3 million |
2021-06-30 | 1.9 million | 1.5 million |
2021-03-31 | 1.9 million | 8.1 million |
ACUR Free Cash Flow and Stock based compensation
No data available :(
ACUR Net Income
No data available :(
ACUR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2021-12-31 | - | - | - |
2021-09-30 | - | - | 58000 |
2021-06-30 | - | - | 66000 |
2021-03-31 | - | - | - |
ACUR Shares Outstanding
ACUR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2021-12-31 | - | - | - | - |
2021-09-30 | - | 385000 | 416000 | - |
2021-06-30 | - | 390000 | 523000 | - |
2021-03-31 | - | 405000 | 385000 | - |
ACUR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2021-12-31 | - | - |
2021-09-30 | 270000 | - |
2021-06-30 | 613000 | - |
2021-03-31 | 644000 | - |
ACUR
Price: $0
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -0.10
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 3600
Ebitda: -1.4 millionMarket Capitalization: 270607